Skip to content
Roboearth – Lifestyle
Author:
Eloxx Pharmaceuticals, Inc.
Eloxx Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
August 12, 2026
Eloxx Pharmaceuticals, Inc. Announces Pricing of $66.0 Million Public Offering and Uplisting to Nasdaq
June 8, 2026